Xbrane Biopharma AB (publ) (STO:XBRANE)
Sweden
· Delayed Price · Currency is SEK 0.2520
+0.0016 (0.64%)
Jun 27, 2025, 5:29 PM CET
Xbrane Biopharma AB Market Cap
Xbrane Biopharma AB has a market cap or net worth of 364.35 million as of June 27, 2025. Its market cap has decreased by -22.78% in one year.
Market Cap
364.35M
Enterprise Value
489.25M
Revenue
277.89M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.25
Market Cap Chart
Since February 3, 2016, Xbrane Biopharma AB's market cap has increased from 131.05M to 364.35M, an increase of 178.02%. That is a compound annual growth rate of 11.49%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 95.21B |
| Sectra AB | 65.20B |
| Getinge AB | 50.58B |
| Asker Healthcare Group AB | 40.96B |
| Medicover AB | 35.78B |
| Camurus AB | 35.18B |
| AddLife AB | 21.97B |
| Vimian Group AB | 21.09B |